Behavioral science to improve cattle well-being Behavioral science to improve cattle well-being Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being
Soaring to save lives Soaring to save lives Tackling health disparities through drone delivery of vaccines animals and livestock living in underserved communities
International Women’s Day: gender and health equity International Women’s Day: gender and health equity On International Women’s Day, we join forces to collectively strive for gender and health equity, empowering women in and beyond our company.
Agile working as a mindset Agile working as a mindset How does an agile mindset foster innovation? Read about collaboration, user-centricity and rapid learning cycles
Fast-Track-Designation-NASH Fast-Track-Designation-NASH Boehringer Ingelheim and Zealand Pharma announced that the FDA granted Fast Track Designation to the dual agonist BI 456906 for adults with NASH.
Advance study vaccinating increased milk production Advance study vaccinating increased milk production [New ADVANCE study shows vaccinating with Bovela® results in increased milk production
12th Expert Forum on Farm Animal Well-Being 12th Expert Forum on Farm Animal Well-Being The 12th Expert Forum on Farm Animal Well-Being brought together over 100 industry experts
Making sustainable medicines through eco-design Making sustainable medicines through eco-design Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Ukraine Help: We fly, we bike, we accommodate Ukraine Help: We fly, we bike, we accommodate The solidarity for Ukraine from Boehringer Ingelheim employees is incredible. Equally impressive is their practical help.
The status of schizophrenia care The status of schizophrenia care A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
How do our donations for Ukraine help? How do our donations for Ukraine help? The war in Ukraine continues to cause suffering and hardship. The Polish and the German Red Cross – also supported by donations from us – help to the best of their ability.
View from Both Sides of the Table View from Both Sides of the Table Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
Circular economy: Taking action to reduce plastic waste Circular economy: Taking action to reduce plastic waste The packaging department team at Yamagata, Japan, managed to reduce their waste plastic material for a greener and more sustainable tomorrow
1990-2023: Value through Innovation 1990-2023: Value through Innovation The Boehringer Ingelheim history from 1990 to 2023, with milestones
Innovation from within Innovation from within Justine Rochon and Marc Weimer talk about the transformation of Biostatistics and Data Sciences (BDS) into a modern organisation in drug development.
EU approved Jardiance for type 2 diabetes in children EU approved Jardiance for type 2 diabetes in children Jardiance® (empagliflozin) receives approval in the EU for the treatment of type 2 diabetes in children aged 10 years and above
1948-1990: Going global 1948-1990: Going global The Boehringer Ingelheim history from 1948-1990, with milestones
Why cancer care is personal for us Why cancer care is personal for us At Boehringer Ingelheim, we have made a generational commitment to transforming cancer care, with the ultimate goal of curing a range of cancers.
FDA approval NexGard PLUS for dogs FDA approval NexGard PLUS for dogs Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS - A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites
Growing with us Growing with us We recognize the benefits of learning and have created an environment where life-long learning and personal growth are encouraged for all employees.
World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination
Geographic Atrophy treatment to move to Phase II Geographic Atrophy treatment to move to Phase II Geographic Atrophy treatment BI 771716 to move to Phase II, following positive Phase I results
New positive data in Phase III type 2 diabetes trial New positive data in Phase III type 2 diabetes trial DINAMO Phase III trial demonstrated empagliflozin significantly reduced blood sugar levels in children and adolescents with type 2 diabetes